Literature DB >> 82016

Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis.

M Campieri, G A Lanfranchi, G Bazzocehi, C Brignola, G Corazza, C Cortini, M Michelini, G Labó.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82016     DOI: 10.1016/s0140-6736(78)92556-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

3.  Lack of effect of 5-aminosalicylic acid on platelet aggregation and fibrinolytic activity in vivo and in vitro.

Authors:  K Winther; S Bondesen; S H Hansen; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

5.  Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.

Authors:  H Allgayer; J Eisenburg; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Inhibition of leucocyte motility by drugs used in ulcerative colitis.

Authors:  J M Rhodes; T C Bartholomew; D P Jewell
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

7.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

Review 8.  Antidiarrheal therapy. Prospects for new agents.

Authors:  R N Fedorak; M Field
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

9.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

10.  4-Aminosalicylic acid retention enemas in treatment of distal colitis.

Authors:  J Gandolfo; M Farthing; G Powers; K Eagen; M Goldberg; P Berman; M Kaplan
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.